A secondary prevention programme of ischaemic heart disease in the elderly

Is a secondary prevention program compared with usual care effective to improve the achievement of cardiovascular risk factors goals in patients = 70 years old with recent acute coronary syndrome?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN17382091

Enrollment

120

Registered

2016-10-01

Start date

2004-09-01

Completion date

Unknown

Last updated

2023-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease Circulatory System Coronary heart disease

Interventions

Patients will be recruited before hospital discharge, and are randomized to an intervention or control group within the next three months. Patients will be randomised by a balanced randomised block me

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Consecutive patients =70 years old 2. Diagnosed with acute coronary syndrome 3. Admitted to the Cardiology Department of the Bellvitge University Hospital

Exclusion criteria

Exclusion criteria: 1. Diagnosis of cancer 2. Functional dependence (Barthel Index score =75) 3. Cognitive impairment (Pfeiffer’s Short Portable Mental State Questionnaire >5 mistakes) 4. Difficulties attending appointments 5. Very low life expectancy

Design outcomes

Primary

Measure	Time frame
1. Blood pressure is measured during patient interviews using a digital sphygmomanometer at baseline and 12 months 2. LDL cholesterol is measured by a fasting blood test performed the week before the appointments at baseline and 12 months 3. Smoking status is assessed during patient interviews at baseline and 12 months 4. Body mass index is caclulated during patient interview using the weight and height measurements at baseline and 12 months 5. Physical activity is measured using the Metabolic Equivalent of Task (MET) h/wk during patient interviews at baseline and 12 months 6. Glycosylated haemoglobin is measured by a fasting blood test performed the week before the appointments at baseline and 12 months	—

Measure

Time frame

1. Blood pressure is measured during patient interviews using a digital sphygmomanometer at baseline and 12 months 2. LDL cholesterol is measured by a fasting blood test performed the week before the appointments at baseline and 12 months 3. Smoking status is assessed during patient interviews at baseline and 12 months 4. Body mass index is caclulated during patient interview using the weight and height measurements at baseline and 12 months 5. Physical activity is measured using the Metabolic Equivalent of Task (MET) h/wk during patient interviews at baseline and 12 months 6. Glycosylated haemoglobin is measured by a fasting blood test performed the week before the appointments at baseline and 12 months

—

Secondary

Measure	Time frame
1. Adherence to the Meditrranean Diet is measured with a nine-item score (Martínez- González, 2004) calculated from the food-frequency questionnaire performed during patient interview at baseline and 12 months 2. Quality of life is measured using the Short Form 36 Health Survey at baseline and 12 months 3. Physical performance is measured using the Short Physical Performance Battery (SPPB) during patient interviews at baseline and 12 months 4. Mortality rate is assessed three years after the 12-month follow-up using clinical records and the National Death Index	—

Measure

Time frame

1. Adherence to the Meditrranean Diet is measured with a nine-item score (Martínez- González, 2004) calculated from the food-frequency questionnaire performed during patient interview at baseline and 12 months 2. Quality of life is measured using the Short Form 36 Health Survey at baseline and 12 months 3. Physical performance is measured using the Short Physical Performance Battery (SPPB) during patient interviews at baseline and 12 months 4. Mortality rate is assessed three years after the 12-month follow-up using clinical records and the National Death Index

—

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026